Rising Prevalence Of Influenza And Growing Awareness Regarding Early-Stage Disease Diagnosis In The North America Region Is Set To Stimulate The Market Trends; States Fact.MR
Fact.MR, a market research and competitive intelligence provider: The global Influenza Diagnostics market reached a valuation of US$ 2.5 Bn in 2020, and is anticipated to top US$ 4 Bn by 2031, expanding at a CAGR of 5%.
Source: biospace.com